Services search (in the department)
Illness | Number of cases |
---|---|
Malignant neoplasm of prostate (C61) | 48 |
Hyperplasia of prostate (N40) | 42 |
Other specified abnormalities of plasma proteins (R77.80) | 30 |
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) | 27 |
Calculus of kidney and ureter - Calculus of ureter (N20.1) | 22 |
Calculus of kidney and ureter - Calculus of kidney (N20.0) | 21 |
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 18 |
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 17 |
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 12 |
Other disorders of bladder - Bladder-neck obstruction (N32.0) | 11 |
Treatment | Number |
---|---|
Injection or administration of medicines into the urinary bladder (8-132.3) | 168 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 81 |
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 76 |
Dilatation of the ureters during an operation or endoscopy (5-560.2) | 74 |
Examination of the urethra and the urinary bladder by endoscopy (1-661) | 68 |
Injection or administration of medicines into the urinary bladder (8-132.2) | 63 |
(5-98k.0) | 59 |
Insertion, exchange or removal of a ureteral stent (8-137.00) | 52 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) | 36 |
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 32 |
Department key: 2200
Inpatient department
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 0 |
Number | Group |
---|---|
48 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
31 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
27 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
No. | Training in other healing professions | Comment |
---|---|---|
HB19 | Nursing professionals | Dreijährig examiniertes Pflegepersonal |
HB17 | Auxiliary nurse (m/f) | Einjährig examiniertes Pflegepersonal |
Herr Gunnar Schramm
Geschäftsführer
Phone:
09372
-700-1000
Mail:
ed.tiehdnuseg-soileh@mmarhcS.rannuG
Frau Natascha Breunig
Beschwerdemanagement
Phone:
09372
-700-1065
Mail:
ed.tiehdnuseg-soileh@hcabnelrE.gnunieM
Frau Natascha Breunig
Qualitätsmanagementbeauftragte
Phone:
09372
-700-1065
Mail:
ed.tiehdnuseg-soileh@ginuerB.ahcsataN
Herr CA Dr. Siegfried Beller
Vorsitzender
Phone:
09372
-700-1960
Mail:
ed.tiehdnuseg-soileh@relleB.deirfgeiS
Ärztlicher Direktor / Herr Chefarzt Dr. Michael Weberpals
Vorsitzender
Phone:
1920
-700-1920
Mail:
ed.tiehdnuseg-soileh@slaprebeW.leahciM
Herr Peter Sattler
Abteilungsleiter Apotheke
Phone:
0611
-43-3673
Mail:
ed.tiehdnuseg-soileh@relttaS.reteP